Detection and in silico evaluation of undeclared venlafaxine and clomethiazole in a counterfeit herbal product marketed for alcohol withdrawal syndrome
- 11 October 2025
- journal article
- Published by Elsevier in Journal of Pharmaceutical and Biomedical Analysis
- Vol. 268, 117189
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Novel 4-((3-fluorobenzyl)oxy)benzohydrazide derivatives as promising anti-prostate cancer agents: Synthesis, characterization and in vitro & in silico biological activity studiesJournal of Molecular Structure, 2024
- 1-Benzhydryl-piperazine: Isolation, structure determination, and in silico studies for a novel potential narcotic agent detected in sports supplementsJournal of Food Composition and Analysis, 2024
- Fatal overdose with a combination of SNRIs venlafaxine and duloxetineForensic Science, Medicine and Pathology, 2019
- Monitoring drug–serum protein interactions for early ADME prediction through Surface Plasmon Resonance technologyJournal of Pharmaceutical and Biomedical Analysis, 2017
- Understanding and fighting the medicine counterfeit marketJournal of Pharmaceutical and Biomedical Analysis, 2014
- Determination of venlafaxine in post-mortem whole blood by HS-SPME and GC-NPDForensic Science International, 2012
- The global counterfeit drug trade: Patient safety and public health risksJournal of Pharmaceutical Sciences, 2011
- Demographics of suicide victims in Sweden in relation to their blood–alcohol concentration and the circumstances and manner of deathForensic Science International, 2010
- Application of LC–ESI–MS–MS for detection of synthetic adulterants in herbal remediesJournal of Pharmaceutical and Biomedical Analysis, 2006
- Driving under the influence of chlormethiazoleForensic Science International, 2005